first glp 1 approved for weight loss The FDA has the pill version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body FDA Approves First Generic GLP-1
Description
Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those without obesity.

Food and Beverage Industry Adaptations Morgan Stanley Research's projections suggest a significant shift in dietary patterns by 2035, attributed to an estimated 7% of the U.S
Charge variants5
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
The GLP-1 drugs have favorable actions well beyond weight loss
As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials
